Research Analysts Offer Predictions for Humana Inc.’s Q1 2017 Earnings (HUM)

Humana Inc. (NYSE:HUM) – Leerink Swann issued their Q1 2017 EPS estimates for Humana in a report released on Thursday. Leerink Swann analyst A. Gupte forecasts that the firm will post earnings of $2.32 per share for the quarter. Leerink Swann also issued estimates for Humana’s Q2 2017 earnings at $2.83 EPS, Q3 2017 earnings at $3.37 EPS, Q4 2017 earnings at $2.48 EPS and FY2019 earnings at $14.39 EPS.

A number of other equities analysts have also recently issued reports on the company. RBC Capital Markets restated a “hold” rating and issued a $207.00 target price on shares of Humana in a report on Friday. Piper Jaffray Companies began coverage on Humana in a report on Tuesday, January 3rd. They issued an “overweight” rating and a $231.00 target price on the stock. Cantor Fitzgerald began coverage on Humana in a report on Monday, February 6th. They issued a “neutral” rating and a $186.00 target price on the stock. Jefferies Group LLC restated a “buy” rating and issued a $206.00 target price on shares of Humana in a report on Monday, November 7th. Finally, JPMorgan Chase & Co. upgraded Humana from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $163.00 to $202.00 in a report on Thursday, November 10th. Nine research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $209.27.

Earnings History and Estimates for Humana (NYSE:HUM)

ILLEGAL ACTIVITY NOTICE: This news story was originally published by sleekmoney and is the property of of sleekmoney. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this news story can be viewed at http://sleekmoney.com/research-analysts-offer-predictions-for-humana-inc-s-q1-2017-earnings-hum/1655459.html.

Shares of Humana (NYSE:HUM) opened at 205.43 on Friday. Humana has a 52 week low of $150.00 and a 52 week high of $217.80. The firm has a market capitalization of $30.63 billion, a price-to-earnings ratio of 27.78 and a beta of 0.91. The firm’s 50-day moving average price is $201.80 and its 200 day moving average price is $187.94.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, February 8th. The insurance provider reported $2.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.05 by $0.04. The company earned $12.88 billion during the quarter, compared to analyst estimates of $13.55 billion. Humana had a return on equity of 13.09% and a net margin of 1.09%. The firm’s revenue was up .7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.45 earnings per share.

Several institutional investors have recently bought and sold shares of HUM. Acrospire Investment Management LLC acquired a new position in Humana during the third quarter worth approximately $106,000. Daiwa SB Investments Ltd. raised its position in shares of Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares in the last quarter. Brown Brothers Harriman & Co. purchased a new position in shares of Humana during the third quarter valued at about $134,000. First Bank & Trust purchased a new position in shares of Humana during the fourth quarter valued at about $142,000. Finally, People s United Financial Inc. raised its position in shares of Humana by 141.6% in the third quarter. People s United Financial Inc. now owns 853 shares of the insurance provider’s stock valued at $151,000 after buying an additional 500 shares in the last quarter. Institutional investors and hedge funds own 92.74% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by sleekmoney and is the property of of sleekmoney. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this news story can be viewed at http://sleekmoney.com/research-analysts-offer-predictions-for-humana-inc-s-q1-2017-earnings-hum/1655459.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/research-analysts-offer-predictions-for-humana-inc-s-q1-2017-earnings-hum/1655459.html

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *